Amniotic Membrane Market (By Enzyme: Cryopreserved Amniotic Membrane, Dehydrated Amniotic Membrane; By Application: Surgical Wounds, Ophthalmology, Others; By End-use: Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Research and Academic Institutes) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 160

Introduction

The global amniotic membrane market is project worth $ 5.83 Billion by 2026 and the market is projected to showcase 12.7% CAGR during the forecast period. Increasing awareness among the people in the recent past has led to a surge in the number of transplants leading to rising demand for these tissue-based products. It has also led to increase in the number of donations thus, boosting market growth.

Market Dynamics

Increasing hazardous cases in trauma, burnt cases and leading to cure through surgeries, also increasing awareness highlighting the benefits of amniotic membrane based products are boosting the demand for the products driving the global amniotic membrane market. Increasing cases of cosmetic surgeries performed worldwide is also another factor likely to drive the growth of market during the forecast period. Amniotic membrane is also being utilized in the healing of a large number of ocular surface diseases as it protects surfaces from microbial colonization minimizing the risk of infections.

Market Insights

Numerous NGOs such as American Association of Tissue Banks which regulates tissue donation in the U.S. Presence of similar tissue banks is to ensure zero infection transmission which leads to diseases, which, sequentially, accelerates market growth by increasing the demand. Moreover, a number of medical institutions are trying to bring in novel areas of application for these products by focusing on the research activities in regenerative medicines and applications of stem cell. This is among the other prime factors that are likely to maintain market expansion globally. Cryopreserved amniotic membrane is widely used in hospitals, Ambulatory Surgical Centers (ASCs), and few other specialty clinics. Lyophilization of the tissue post donation conserve the biological and histological activity of the tissue facilitating faster wound recovery.

Market Segmentation

Market By Enzyme

  • Cryopreserved Amniotic Membrane
  • Dehydrated Amniotic Membrane

Market By Application

  • Surgical Wounds
  • Ophthalmology
  • Others

Market By End-use

  • Hospitals,
  • Ambulatory Surgical Centers (ASCs),
  • Specialty Clinics,
  • Research and Academic Institutes

Market By Geography

  • North America
    • U. S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

Among the regions, North America amniotic membrane market is a leading having the maximum share owing to presence of a large number of key companies and high incidence of infectious and chronic diseases. This region is expected to continue having the maximum market share during the forecast period. The Asia Pacific amniotic membrane market is anticipated to record the highest CAGR during the forecast period owing to growing population and rising incidence of burn injuries and chronic diseases.

Market Participants

The key players catering to the global amniotic membrane market are Amnio Technology, Alliqua BioMedical Inc.; Applied Biologics LLC; Katena Products, Human Regenerative Technologies DermaSciences; Skye Biologics, Inc. and MiMedx Group Inc. The global players are continuously investing in R&D activities and innovating to have updated product portfolio to attract more and more business opportunity from the emerging nation such as India and China. Further changing customers’ preferences are encouraging global players to develop innovative technology solution to cater best to the market. Also, Increasing R&D investments coupled with technological advancements to commercialise highly efficient products are anticipated to offer lucrative opportunities for industry participants.


Related Reports

Minimally Invasive Surgical Instruments Market (By Device: Handheld Instruments, -Inflation Devices, Cutter Instruments, Guiding Devices, Electrosurgical Devices, Auxiliary Devices, Monitoring & Visualization Devices; By Application: Cardiac, Gastrointestinal, Orthopedic, Vascular, Gynecological, Urological, Thoracic, Cosmetic, Dental, Others; By End-user: Hospitals & Clinics, Ambulatory Surgical Centers) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global minimally invasive surgical instruments is market size is anticipated to around USD 39.0 billion by 2026, this market is anticipated to grow with 10.1% CAGR during the forecast time period. The inclination for Minimally Invasive Surgical (MIS) techniques is increasing as they are less traumatic and they encourage quicker recoup process than

NET Treatment Market (By Product: Somatostatin Analogs (SSAs), Targeted Therapy, Others; By Site: Lungs, Pancreas, Colon, Small Intestine, Others; By End-user: Hospitals, Clinics, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global NET treatment is market size is anticipated to around USD 4.2 billion by 2026, this market is anticipated to grow with 10.1% CAGR during the forecast time period. The market is driven by growing occurrence of cancer among patients is expected to drive NET treatment market growth across the global.

Embolic Protection Devices Market (By Product: Distal Occlusion Filters, Proximal Occlusion Filters, Distal Filters; By Application: Neurovascular Diseases, Cardiovascular Diseases, Peripheral Vascular Diseases) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global embolic protection devices market size is anticipated to reach USD 2.0 billion by 2026, registering at a CAGR growth of 9.2% over the forecast period. Increasing cases of cardiovascular, neurovascular surgeries and also surge in huge investments in R&D of embolic devices are the main features driving the market development.

Cart Summary